Abstract Apolipoprotein A-IV (apoA-IV, protein; APOA4, gene) is a major constituent of high-density lipoprotein (HDL) and triglyceride-rich lipoprotein particles, but its precise function in lipid metabolism is still uncertain. We have determined APOA4 genetic polymorphism in 285 randomly selected Melanesians from the Solomon Islands and have evaluated its significance in lipid metabolism. By using isoelectric focusing and immunoblotting techniques, a variant pattern, indistinguishable from the APOA4*2 allele uniquely found in white populations at a frequency of about 8%, was detected at a relatively high frequency (19%) in the Melanesian sample. Polymerase chain reaction (PCR) amplification and DNA sequencing of the 3' end of theAPOA4 gene revealed that the Melanesian mutation is distinct from the known APOA4*2 mutation and that it involves a four-amino acid deletion in the evolutionarily conserved carboxyl-terminal region in the apoA-IV protein, which consists of four repeats of four amino acids each. After adjustment for concomitant variables, we A polipoprotein (apo) A-IV (apoA-IV, protein; / \ APOA4, gene) has been suggested to play an A. A . important role in the metabolism of highdensity lipoproteins (HDLs) and triglyceride-rich lipoprotein particles. For example, apoA-IV has been shown to be a potentiator of plasma HDL conversion factor, 1 it can act as a ligand for the putative HDL receptors, 2 " 5 and it is involved in the activation of lecithinxholesterol acyltransferase (LCAT), a key enzyme in the esterification of HDL cholesterol 6 and in the efflux of cholesterol from peripheral cells. 4 ' 78 ApoA-IV has also been postulated to modulate the activity of lipoprotein lipase (LPL) in the presence of apoC-II, 9 and its deficiency may be associated with fat malabsorption.
structural gene coding for the human APOA4 gene is located on chromosome llq in a tightly linked cluster with the APOA1 and APOC3 genes. 1319 Several genetic polymorphisms in the human APOA4 gene have been reported both at the protein and DNA levels. The most commonly studied polymorphism, which is due to a point mutation at codon 360 and involves the conversion of glutamine to histidine, 20 has been investigated at the protein level by isoelectric focusing. The frequency of the less common allele (APOA4*2) varies from 0% to 11% (reviewed in Kamboh and Ferrell 21 ). Judging from the frequency distribution of the APOA4*2 allele, it appears that this allele is unique to the Caucasian gene pool, and its presence at low levels in other population groups is due to Caucasian admixture. Other alleles detected at the protein level include A4*0, A4*3, A4*4, A4*5, A-4*6, and A4*7, and with the exception of the A4*5 allele all other alleles are detected as rare variants in the general population. At the DNA level several other polymorphisms have also been described, but their distribution pattern has yet to be studied in detail in various population groups. The physiological role of the codon 360 mutation in affecting plasma lipid profile has been studied in detail, 2229 but because of inconsistent findings, no clear-cut role has been assigned to this mutation. In this article we describe the detection of a unique and common APOA4 deletion polymorphism in a Melanesian population from the Solomon Islands and its impact on apolipoprotein and lipid levels. 
Methods The Population
For this study a subset of 285 plasma samples was derived from the Solomon Islands Project. 30 ' 31 All samples were collected from subjects in a fasting state, and the results of lipid and apolipoprotein quantitation have been published previously. 32 The Solomon Islands are part of the great island chain that extends eastward from southeast Asia north of Australia to New Caledonia in the Pacific. The present sample is a collection of six subpopulation groups from three islands:
, and one from the Ontong Java atoll population (n=32) to the north of the main island chain. The Bougainville groups are Melanesians and speak non-Austronesian languages. The Malaita groups are also Melanesians but speak Austronesian languages, and the Ontong Javanese speak a Polynesian language with some Melanesian and Micronesian admixture. A detailed description of these Solomon Island groups is given by Friedlaender. 30 - 31 Previous genetic studies suggest that the three groups on Bougainville Island are closely related, as are the two groups on the Malaita Island. The people from Ontong Java are genetically closer to the people of Malaita Island. 31 In this study we have pooled data from all groups because there were not enough individuals in each group for separate analysis; furthermore, the APOA4 allele frequencies were similar in most of the groups with relatively higher numbers.
Lipid and Apolipoprotein Quantitation
Fasting samples were collected in 0.15% EDTA and quantified for total cholesterol, triglyceride, apoA-I, apoA-II, and apoE levels; the results for the whole sample have been described previously. 32 We reestimated these values in the subset data of 285 subjects (109 men, 176 women). Because no significant difference was observed between men and women, the data were combined; the mean values are shown in Table  1 and are comparable with the whole data set reported previously.
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APOA4 Phenotyping
APOA4 phenotyping was carried out by isoelectric focusing (IEF) and immunoblotting protocols as described previously. 33 Briefly, 5% polyacrylamide gels containing 6 mol/L urea and 2% ampholine, pH 4 to 6.5, were prepared. Plasma samples absorbed on 5x4-mm Whatman 3 MM wicks were applied 1 cm from the cathode, and IEF was carried out at 30 W, 2500 V, and variable amperage for 3 hours at 10°C. The electrode solutions were 1 mol/L H 3 PO 4 for the anode and 1 mol/L NaOH for the cathode. After completion of IEF, proteins were transferred to a nitrocellulose membrane that was sequentially probed for 30 minutes each with 5% (wt/vol) nonfat milk, rabbit anti-human apoA-IV, and goat anti-rabbit IgG conjugated with alkaline phosphatase. Finally, the membrane was histochemically stained to visualize apoA-IV isoprotein bands.
Polymerase Chain Reaction
Amplification of 0.5 to 1.0 jig of genomic DNA was carried out by polymerase chain reaction (PCR) using oligonucleotide primers designed to amplify a 300-nucleotide region in the third exon of the human APOA4 gene (see Fig 2a) . Primer A4 232, 5-CGGGTGGAGCCCTACGGGGA-3' (nucleotides 2163 to 2182), was used as the coding strand, and A4 233, 5'-TGGGGCCAGTGCACCAGGGG-3' (nucleotides 2462 to 2443), was used as the noncoding strand primer. 3435 After denaturation of the template DNA at 98°C for 8 minutes, 30-/xL reaction mixture consisting of 5 /xL of 10 x reaction buffer (100 mmol/L Tris-HCl, pH 8.3, 500 mmol/L KC1, 15 mmol/L MgCl 2 ), 3 /xL dimethyl sulfoxide, 2 /iL (1 ^tmol) of each primer, 1 fiL each of 10 mmol/L dATP, dCTP, dGTP, and dTTP, 1 fiL of Taq DNA polymerase (Perkin-Elmer Cetus Inc), and 13 /xL of sterile deionized water were added to the DNA template. Mineral oil (25 juL) was placed over the final PCR reaction mixture, and amplification was performed by 25 cycles of denaturation (1 minute at 94°C) and annealing and extension (3 minutes at 65°C) followed by extension for 5 minutes at 65°C. The amplified DNAs were separated on 2% agarose gel in 1 x Tris-borate-EDTA buffer, and the APOA4 polymorphism was typed by visualization under UV light (see Fig 2b) .
DNA Sequencing Analysis
Oligonucleotide primers A4 232 and A4 233 were used for amplification and sequencing. The diluted DNA template of 10 fih was added to 90 juL PCR reaction mixture to give a final volume of 100 /iL, without the mineral oil overlay. PCR reaction mixtures were the same as described in the previous section. Asymmetric PCR was performed to produce singlestranded template DNAs for sequencing. For asymmetric PCR, 10 juL of double-stranded PCR product was loaded in 1% low-melting-point agarose, and a gel plug of the product was diluted with 500 fiL water, heated at 65°C for at least 5 minutes, and vortexed. The primer ratio was 100:1. The rest of the asymmetric PCR reaction mixture was the same as for symmetric PCR. Before sequencing, the asymmetric PCR products were purified and concentrated by the use of an ultra-free MC cartridge (Millipore). Sequencing was carried out on single-stranded amplified DNA by the dideoxynucleotide chain-termination method using Sequenase Version 2.0 (US Biochemical).
Statistical Analysis
APOA4 allele frequencies (p) were estimated by allele counting and the standard error by the formula [p(l-/>/n)] 1/2 , where n is the total number of individuals tested. HardyWeinberg equilibrium was tested by x 1 goodness-of-fit test. Heterozygosity (h) was computed by summing up the squared allele frequencies and subtracting them from 1
To evaluate the effect of APOA4 polymorphism on the variation of quantitative variables of lipid and apolipoprotein, an ANCOVA was carried out. The distributions of all the variables were tested for normality. Determination of the effects of covariates was done by stepwise regression. Age, sex, and body mass index were considered as covariates. Body mass index was computed as weight in kilograms divided by height in meters squared. All statistical analyses were done using the statistical software package SAS. The average effects of APOA4 were estimated according to the method of Templeton. on an isoelectric focusing (IEF) gel. APOA4 isoforms were separated on an IEF gel containing 2% ampholine, pH range 4 to 6.5, and 6 mol/L urea, followed by blotting and immunostaining with polyclonal rabbit anti-human apolipoprotein A-IV serum.
The position of the anode is indicated by an arrow.
Results
AP0A4 Phenotyping
Two hundred eighty-five plasma samples were screened for AP0A4 protein polymorphism by IEF followed by immunoblotting. Three distinct patterns, as noted previously in Europeans and US whites, were also observed in the Solomon Islanders. As shown in Fig 1, the isoelectric points of these patterns are indistinguishable between the Solomon Islanders and US whites, and accordingly the three phenotypes were designated as 1, 1-2, and 2; their distribution is shown in Table 2 . The most common phenotype, 1, was observed in 64.5% of individuals, followed by the 1-2 phenotype in 33% and the 2 phenotype in 2.5% of individuals; this distribution was in Hardy-Weinberg equilibrium. The allele frequencies of the two alleles APOA4*1 and APOA4*2, which control the biosynthesis of three phenotypes, were .81 and .19, respectively. The observed frequency of the APOA4*2 allele in the Solomon Islands sample was by far the highest frequency previously noted even in Caucasian populations. This was an unexpected finding because this allele is considered to be a unique Caucasian marker, and its presence at a low frequency in non-Caucasian populations is consistent with this hypothesis.
AP0A4 Genotyping
Seventeen DNA samples available on 17 corresponding plasma samples previously typed for the APOA4 protein polymorphism in Melanesians (1 [n=8], 1-2 [n=8], 2 [n=l]) were PCR-amplified using a pair of oligonucleotide primers covering a 300-bp region between nucleotides 2163 and 2462 in the third exon of the human APOA4 gene (Fig 2a) , which harbors the point mutation responsible for the APOA4*2 allele at codon 360. As shown in Fig 2b, the expected fragment of 300 bp was seen in all individuals with the 1 homozygous phenotype, while a smaller fragment of 288 nucleotides was observed in the only individual homozygous for the 2 phenotype. The eight individuals with the 1-2 phenotype showed both fragments of 300 and 288 nucleotides, suggesting that the molecular basis of the Melanesian mutation is a 12-nucleotide deletion rather than a point mutation found in white populations. Based on these results, we reassigned the 1,1-2, and 2 phenotypes as N (normal), NZ) (normal-deletion), andD (deletion) genotypes as shown in Table 1 .
DNA Sequencing
To confirm and localize the 12-nucleotide deletion in the 300-bp fragment, we sequenced the coding and noncoding strands from one normal individual and one individual homozygous for the deletion allele. The sequencing data are shown in Fig 3. The 12-nucleotide deleted sequence was localized near the 3' end of the APOA4 coding sequence, which consists of four repeated units coding for four amino acids each in the mature apoA-IV protein. The deletion is responsible for the elimination of one repeated unit that codes for four-amino acid residues, glutamic acid (GAG), glutamine (CAG), glutamine (CAG), and glutamine (CAG) between codons 362 to 365 (nucleotides 2391 to 2402). Because of the elimination of one negatively charged residue (glutamic acid) in the mature protein, the IEF point of the deleted allele APOA4*D is more basic than the normal allele product, APOA4*N. This explains why the focusing position of the APOA *D allele is identical to the APOA4*2 allele on IEF gels: the mutation for the APOA4*2 allele at codon 360 adds one positively charged residue (histidine) to the mature protein, which turns the mutated protein more basic than the normal allele product.
Impact of the Deletion Allele on Lipid and Apolipoprotein Levels
The adjusted mean values of cholesterol, triglycerides, apoA-I, apoA-II, and apoE among the three APOA4 genotypes N, ND, and D are given in Table 3 . There was a clear gene-dosage effect on the levels of cholesterol, apoA-I, and apoA-II among the three genotypes: These levels were highest in the N genotype, lowest in the D genotype, and intermediate in the ND genotype. A gene-dosage effect was also observed on triglyceride levels, but in a direction opposite to that seen for cholesterol, apoA-I, and apoA-II. However, despite this clear gene-dosage effect on four quantitative traits, only the apoA-I and apoA-II levels varied significantly (P= .02) among the APOA4 genotypes; this variation explains about 3% of the phenotypic variance in both apolipoproteins. The average effect of the APOA4*D allele was to lower apoA-I and apoA-II by 8 mg/dL and 2 mg/dL, respectively, compared with the APOA4*N allele (Fig 4) .
Discussion
Although the exact function of apoA-IV in lipid metabolism is still unknown, in vitro evidence suggests its potential involvement in the metabolism of HDL and triglyceride-rich lipoprotein particles. Studies of common and unique mutations in several other apolipoproteins have helped to define the roles of these apolipoproteins in lipid metabolism, 37 Blots showing DNA sequence analysis of coding strands from two Melanesians who were homozygous either for the normal allele or for the 12-bp deletion allele. The DNA sequence for the four conserved tandem repeats is given for the normal allele. In the deletion allele the third of the four repeats is eliminated. The sequence data were also confirmed on noncoding strands (data not shown).
will be helpful for apoA-IV. So far, a number of mutations, both common and rare, have been identified in the APOA4 gene, but with the exception of a few, the physiological role of other mutations has yet to be studied in detail in various population groups. In this regard the most studied mutation is at codon 360, but owing to a relatively low frequency of this mutation in the general population, a reliable estimate of the impact of this mutation in lipid metabolism has proven to be unsuccessful. Discovery of new and common mutations in the APOA4 gene may help solve this problem. In this study we have screened a Melanesian population from the Solomon Islands and have found a unique polymorphic deletion in the APOA4 gene that affects significantly the quantitative levels of apoA-I and apoA-II. Although the IEF position of the deletion allele found in Melanesians is identical to the previously described APOA4*2 mutation at codon 360, the molecular bases of these mutations are distinct from each other. The APOA4*2 mutation involves a point mutation at codon 360 that converts the commonly occurring glutamine residue (CAG) to histidine (CAT), while the basis of the deletion allele is the elimination of four amino acids, Glu-Gln-Gln-Gln, at codons 362 to 365. Because both mutations add one positive charge to the variant protein (in APOA4*2 caused by the presence of a positively charged amino acid, histidine, and in APOA4*D caused by the elimination of a negatively charged residue, glutamic acid, compared with the normal protein), they occur at the same position on IEF gels. The allele frequency of APOA4*D (19%) in the Solomon Islands is about 2.5-fold the average frequency of the APOA4*2 allele (8%) found among whites. Recently we have identified an identical deletion in the chimpanzee APOA4 gene with a similar allele frequency (19%) that also involves elimination of four amino acids in the third of the four repeats. 39 In comparison with the common occurrence of the APOA4 deletion polymorphism in Melanesians, this has been detected as a rare variant in blacks 40 (M.I.K., unpublished data). In addition to the deletion of a single repeat of four amino acids in the carboxyl-terminal region of the human apoA-IV protein, an insertion of a single repeat of four amino acids has also been found in the APOA4*0 40 < 41 and APOA4*5 A2 variant alleles. This evolutionarily conserved region appears to be the subject of frequent insertion/deletion polymorphisms because, in addition to humans and chimpanzees, such mutations in this region are found in mice 43 and baboons.
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To determine the physiological role of this deletion polymorphism in lipid and lipoprotein metabolism, we investigated the impact of this polymorphism on interindividual differences in cholesterol, triglycerides, apoA-I, apoA-II, and apoE. Significant variability among the three genotypes N, ND, and D was observed for apoA-I (P=.O2) and apoA-II (P=.O2) levels. These differences were directional: the highest levels were observed in individuals homozygous for the normal genotype (N) and the lowest levels in individuals homozygous for the deleted allele (D); individuals with the heterozygous genotype (ND) had intermediate values.
The AP0A4*N and the APOA4*D alleles account for about 3% of the variation in both apoA-I and apoA-II levels. A similar gene-dosage effect was noted for cholesterol, but the intergenotype differences were not statistically significant at the 5% level. In this study we could not measure the effect of the deletion allele on HDL cholesterol because these levels were not measured in this sample. In future studies, however, it will be interesting to determine whether the deletion allele has a similar impact on HDL cholesterol as-was seen on apoA-I and apoA-II levels, since these apoiipoproteins are major components of HDL particles. These findings suggest that the four-amino acid deletion in the evolutionarily conserved region may directly affect HDL metabolism. For example, it has recently been shown that secreted apoA-IV is associated mainly with HDL particles, 45 and the deletion allele may affect the synthesis and secretion of HDL particles, resulting in low levels of plasma HDL. Another mechanism that may result in reduced HDL levels is less efficient activation of the LCAT enzyme by the deletion allele. If the above mentioned hypotheses are true, then one can expect that an insertion in this conserved region may enhance HDL synthesis and secretion of apoA-IV as well as the activity of LCAT, resulting in increased levels of plasma HDL. Indeed, this has been found in the case of the APOA4*5 allele, which involves an insertion of four amino acids in this region and is associated with high HDL cholesterol. 42 Alternatively, the effect of the APOA4 deletion allele on HDL metabolism may operate indirectly through its effect on LPL activity, which is required for hydrolysis of core triglycerides of triglyceride-rich lipoprotein particles. A positive correlation between HDL cholesterol and LPL activity has been found in several studies. 4648 ApoA-IV has been shown to increase LPL activity in the presence of apoC-II, 9 an essential cofactor for LPL activity, and it has been suggested that apoA-IV is required for the efficient release of apoC-II from HDL to triglyceride-rich lipoprotein particles. Indeed, it has been shown in in vivo studies that apoA-IV associated with chylomicrons is transferred to HDL 49 and that HDL apoA-IV mass is increased postprandially. 50 In this case the deletion allele may be less effective in transferring apoC-II from HDL to triglyceride-rich lipoprotein particles, which results in decreased LPL activity and therefore slows the catabolism of triglyceride-rich lipoprotein particles, resulting in high plasma triglyceride and low HDL levels. This mechanism is supported here by the fact that a reverse trend was observed in the distribution of triglyceride levels among the three genotypes compared with that seen for apoA-I and apoA-II levels. As shown in Fig 4, the effect of the deletion allele was to increase triglycerides by 12 mg/dL and to lower apoA-I and apoA-II by 8 mg/dL and 2 mg/dL, respectively, compared with the normal allele. If the insertion or deletion of four-amino acid repeat units in the carboxyl terminal in the apoA-IV protein affects the displacement of apoC-II between lipoproteins in vivo, these polymorphisms are of significant importance in regulating the postprandial metabolism of lipoproteins. Studies of these mutations in nonfasting samples will shed more light on the physiological function of apoA-IV in lipid metabolism.
